Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan (2012)
- Autores:
- Autor USP: KANO, EUNICE KAZUE - FCF
- Unidade: FCF
- Assuntos: ANTICORPOS MONOCLONAIS; FARMACOVIGILÂNCIA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 48, suppl. 1, p. 27 res. FCF049, 2012
- Nome do evento: Pharmaceutical Science and Technology Meeting
-
ABNT
RODRIGUES, Lara cheliz e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 07 maio 2024. , 2012 -
APA
Rodrigues, L. cheliz, Ribeiro, A. G., & Kano, E. K. (2012). Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Rodrigues L cheliz, Ribeiro AG, Kano EK. Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 27 res. FCF049.[citado 2024 maio 07 ] -
Vancouver
Rodrigues L cheliz, Ribeiro AG, Kano EK. Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 27 res. FCF049.[citado 2024 maio 07 ] - Osteonecrosis of jaw in use of bisphosphonates
- Assessment of safety and effectivity associated to oseltamivir therapy
- New oral anticoagulants: what do their adverse drug reactions reports suggest?
- Avaliação biofarmacêutica de formulações contendo cefadroxil: estudo in vitro e in vivo (bioequivalência)
- Analysis of adverse drug reaction profile of immunobiological TNF-α inhibitors: a pharmacovigilance overview
- Rituximab and tocilizumab: comparison of profiles of adverse drug reaction
- Use of in silico study to evaluate the effects of different sampling schedules on the assessment of bioequivalence of drugs with long half-life
- Study of drug-related adverse effects of levonorgestrel intrauterine device
- Risk of neuropsychiatric adverse drug reaction associated to use of varenicline tartrate
- Adverse drug reactions profile of new drugs for Hepatits C
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
